ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,581.64
-0.59%
US Tech 100
18,837.20
-0.38%
다우존스 지수
41,468.19
-1.06%
Bitcoin
82,235.04
4.80%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Champions Oncology Inc (CSBR) 시세

Champions Oncology Inc

Champions Oncology Inc (CSBR)

NASDAQ
8.79
-0.11
( -1.24% )
업데이트: 02:59:48
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
8.79
매수가
8.61
매도가
8.92
거래량
15,297
8.601 일간 변동폭 9.23
3.6001 52주 범위 11.99
market_cap
121.471M
전일 종가
8.90
개장가
9.00
최근 거래 시간
1
@
8.795
마지막 거래 시간
02:58:24
재정 규모
US$ 137,421
VWAP
8.9835
평균 볼륨(3m)
55,559
발행 주식
13,819,236
배당수익률
-
주가수익률
-16.35
주당순이익(EPS)
-0.53
매출
50.16M
순이익
-7.28M

Champions Oncology Inc 정보

Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational On... Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.championsoncology.com
본부
Wilmington, Delaware, USA
설립됨
-
Champions Oncology Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker CSBR. The last closing price for Champions Oncology was US$8.90. Over the last year, Champions Oncology shares have traded in a share price range of US$ 3.6001 to US$ 11.99.

Champions Oncology currently has 13,819,236 shares in issue. The market capitalisation of Champions Oncology is US$122.99 million. Champions Oncology has a price to earnings ratio (PE ratio) of -16.35.

CSBR 최신 뉴스

추가 뉴스

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
17 12월 2024
CSBR (-1.24%)

Form 8-K - Current report
Edgar (US Regulatory)
12 12월 2024
CSBR (-1.24%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 11월 2024
CSBR (-1.24%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 11월 2024
CSBR (-1.24%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 11월 2024
CSBR (-1.24%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 11월 2024
CSBR (-1.24%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 11월 2024
CSBR (-1.24%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
01 11월 2024
CSBR (-1.24%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-1.5-14.577259475210.2910.61578.601305049.7976949CS
4-2.66-23.23144104811.4511.828.6013496710.22643992CS
121.825.75107296146.9911.996.11555599.53622417CS
264.8120.300751883.9911.993.75588356.71583447CS
523.0954.21052631585.711.993.6001320126.53429672CS
1560.78.652657601988.0911.993.6001176596.27132514CS
2603.5567.74809160315.2414.683.6001226848.13206951CS

CSBR - Frequently Asked Questions (FAQ)

What is the current Champions Oncology share price?
The current share price of Champions Oncology is US$ 8.79
How many Champions Oncology shares are in issue?
Champions Oncology has 13,819,236 shares in issue
What is the market cap of Champions Oncology?
The market capitalisation of Champions Oncology is USD 122.99M
What is the 1 year trading range for Champions Oncology share price?
Champions Oncology has traded in the range of US$ 3.6001 to US$ 11.99 during the past year
What is the PE ratio of Champions Oncology?
The price to earnings ratio of Champions Oncology is -16.35
What is the cash to sales ratio of Champions Oncology?
The cash to sales ratio of Champions Oncology is 2.37
What is the reporting currency for Champions Oncology?
Champions Oncology reports financial results in USD
What is the latest annual turnover for Champions Oncology?
The latest annual turnover of Champions Oncology is USD 50.16M
What is the latest annual profit for Champions Oncology?
The latest annual profit of Champions Oncology is USD -7.28M
What is the registered address of Champions Oncology?
The registered address for Champions Oncology is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Champions Oncology website address?
The website address for Champions Oncology is www.championsoncology.com
Which industry sector does Champions Oncology operate in?
Champions Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
RAYRaytech Holding Ltd
US$ 2.07
(137.93%)
86.41M
TSVT2seventy bio Inc
US$ 4.945
(76.61%)
29.38M
SYRSSyros Pharmaceuticals Inc
US$ 0.154899
(69.10%)
649.62M
TNONTenon Medical Inc
US$ 1.7793
(42.34%)
31.3M
HSAIHesai Group
US$ 22.37
(39.73%)
21.84M
WCTWellchange Holdings Company Limited
US$ 0.6683
(-73.37%)
26.31M
ARVNArvinas Inc
US$ 8.46
(-51.82%)
12.94M
LZMHLZ Technology Holdings Ltd
US$ 9.58
(-38.83%)
474.79k
SPGCSacks Parente Golf Inc
US$ 0.1059
(-33.85%)
29.25M
ARBBARB IOT Group Ltd
US$ 0.7125
(-28.75%)
2.02M
SYRSSyros Pharmaceuticals Inc
US$ 0.154899
(69.10%)
649.62M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0404
(20.60%)
381.11M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.775
(5.35%)
240.8M
NVDANVIDIA Corporation
US$ 109.03
(1.92%)
236.05M
CUTRCutera Inc
US$ 0.1125
(-12.45%)
208.71M

토론

전체 피드 보기
powerbattles powerbattles 46 초 전
I am now retired and travel a lot. Yes, UNQL is a mess this isn't the merger it's the buyout that works best for Ray scumbag.
Now Ray wanted to cash out an aggregate of 4,693,413,109 shares of Common Stock equal to $17,365,628. That is a sweet deal for him and the noteholders.
UNQL
Jinyinh666 Jinyinh666 1 분 전
Once again these are just amendments not new offerings!!!
BMXI
Jinyinh666 Jinyinh666 1 분 전
Once again these are just amendments not new offerings!!!
BMXI
dinogreeves dinogreeves 2 분 전
I am too Trademax.
TGRP
TooFrank TooFrank 2 분 전
Feel the squeeze. Never trust a broker that wants to pay you for lending you something.
NIO
MikeKnowsRunners MikeKnowsRunners 2 분 전


INVU
nowwhat2 nowwhat2 2 분 전
The West Coast nowwhat ACTION Channel

https://investorshub.advfn.com/uimage/uploads/2025/3/11/wmzbjSPY_~_11_30d_11am_snip_CHAN.jpg
SPY
MikeKnowsRunners MikeKnowsRunners 3 분 전


INVU
Tamboo Tamboo 3 분 전
Bla bla free advise without any fee We know the purpose 
GVSI
la-tsla-fan la-tsla-fan 3 분 전
GL; Let us try and be objective. Tesla's earnings for 24 came to $2.04. So your price represents a P/E of .735. The average P/E of all companies in the US Auto sector is over 19. THEREFORE, YOU think that Tesla, which has been identified as 'more than just an auto company' by most bearish analysts,
TSLA
Penny Stocks 2.0 Penny Stocks 2.0 3 분 전
$UNQL .004 Huge Audited Financials Out!!
UNQL
Penny Stocks 2.0 Penny Stocks 2.0 3 분 전
$UNQL .004 Huge Audited Financials Out!!
UNQL
AlwaysKing AlwaysKing 3 분 전
I'm curious why the share price is dropping after the buy back was initiated last week!...? Has anyone reached out to Cohen to ask him when the buy back is actually going to start because it doesn't look like it's happening at all at this point! A 40% hair cut on our SP with super tiny volume in the
AZRH
researcher59 researcher59 3 분 전
PLAY will report Jan Q4 in a few weeks .... last year it was on 4/2. I think it will be a disappointing report but I could be wrong and some bad news is already priced in. Maybe it will rally despite an earnings miss as happened with DIN. Good luck.
luvthemtrainz luvthemtrainz 3 분 전
So who asked you, skippy?
DBMM
dexprs dexprs 4 분 전
I try to deal with people I know or my neighbors have done business with.
DewDiligence DewDiligence 4 분 전
ARVN—(-52%)—reports purportedly-positive phase-3 data in ER+/HER2- breast cancer:

https://finance.yahoo.com/news/arvinas-pfizer-announce-positive-topline-104500288.html The trial met its primary endpoint in the estrogen receptor 1-mutant (ESR1m) population, demonstrating a statistica
ARVN PFE
janice shell janice shell 4 분 전
I posted one clip:

https://www.cnbc.com/video/2025/03/11/modeling-economic-policy-around-mckinley-tariffs-are-a-suicide-mission-says-roth-capitals-darda.html
vlispxpert vlispxpert 4 분 전
I'm the loneliest bull in the world lmao!
blackhawks blackhawks 5 분 전
Junk science thrives under Republicans.

Congresswoman Rips RFK Jr. For 'Victim Blaming' Child Who Died From Measles
HuffPost Live Updates

Rep. Kim Schrier (D-Wash.), who is a pediatrician, condemned Health and Human Services Secretary Robert F. Kennedy, Jr. for c
Buckey Buckey 5 분 전
I missed him today
MattJames MattJames 5 분 전
not sure id personally wait. I have a good amount of shares. Ive been in this stock for about two months. Im holding for the incline. But what would it hurt to report them now? I mean it's rediculous what they're doing. And that the market makers or whoever is keeping the SP so low. There as to be s
UMAV
crazy horse 0 crazy horse 0 5 분 전
Yeah

Thanks, this happen during the day today?

최근 히스토리

NASDAQ
CSBR
Champions Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지